Abstract
The eye and the brain have limited capacities for regeneration and as such, immune-mediated inflammation can produce devastating consequences in the form of neurodegenerative diseases of the central nervous system or blindness as a result of ocular inflammatory diseases such as uveitis. Accordingly, both the eye and the brain are designed to limit immune responses and inflammation – a condition known as “immune privilege”. Immune privilege is sustained by physiological, anatomical, and regulatory processes that conspire to restrict both adaptive and innate immune responses.
Funder
Research to Prevent Blindness
Subject
Immunology,Immunology and Allergy
Reference56 articles.
1. Germinating Seed in Anterior Chamber;Abel;Rep an unusual case. Arch Ophthalmol,1979
2. The Immunology of Corneal Transplantation;Niederkorn;Dev Ophthalmol,1999
3. The Immune Privilege of Corneal Grafts;Niederkorn;J Leukoc Biol,2003
4. Immune Privilege of Corneal Allografts;Niederkorn;Ocular Immunol Inflammation,2010
5. Immunity to Homologous Grafted Skin. III. The Fate of Skin Homografts Transplanted to the Brain, to Subcutaneous Tissue, and to the Anterior Chamber of the Eye;Medawar;Br J Exp Pathol,1948
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献